维普中文期刊产品整合服务
17篇 您的检索式:作者名="Laur O"
    题名 作者 年代 出处 被引量
1The role of cis dimerization of signal regulatory protein alpha(SIRPalpha)in binding to CD47显示文摘Lee WY Weber DA Laur O 2010J Biol Chem2010,285,37:1
2A regulatory element in the CD95 (AP0-1/Fas)ligand promoter is essential responsiveness to TCR-mediated activation 显示文摘Li-Weber M Laur O Hekele A 1998Ettr J Immunol1998,28,8:1
3et al A regulatory elment in the CD95 (APO-1/Fas)ligand promoter is essential for responsiveness to TCR-mediated activation显示文摘 LAUR O HEKELE A 1998Eur J Immunol1998,28,8:1
4A Java framework for distributed high performance computing显示文摘Laure E O 2001Future Generation Computer Systems2001,18,2:1
5A regulatory clement in the CD95(APO-1/Fas) ligand promoter is essential responsiveness to FCR,mediated activation显示文摘Li-weber M Laur O Hekele A 1998Ear J Lmmunol1998,28,8:1
6Annexin2regulates intestinal epithelial cell spreading and w ound closure through Rho-related signaling显示文摘Babbin BA Parkos CA Mandell KJ Winfree LM Laur O IvanovAI 2007Am J Pathol2007,170,3:1
7( 1 aR,5 aR ) 1 a, 3,5,5a-Tetrahydro-I H-2,3-diaza- cyclopropa E a ] pentalene-4-carboxylic acid ( MK- 1903):a potent GPR109a agonist that lowers free fatty acids in humans 显示文摘BOATMAN P D LAURING B SCHRADER T O 2012J Med Chem2012,55,8:1
8Impact and productivity of harvesting while retaining young understorey spruces in final cutting of downy birch显示文摘Niemist(o)P Korpunen H Laurén A Salom(a)ki M Uusitalo J 0,,01:1
9Reversible inhibition of PSD - 95 mRNA translation by miR -125 a, FMRP phosphorylation, and mGluR signaling显示文摘Muddashetty RS Nalavadi VC Gross C Yao X Xing L Laur O 2011Mol Cell2011,42,5:1
10A regulatory element in the CD95 (APO-Fas) ligand promoter is essential for reponsiveness to TCR-mediated activation 显示文摘Li-Weber M Laur O Hekele A 1998Ear J Immunol1998,28,8:1
11Evolution of lactate/ pyruvate and arterial ketone body ratios in the early course of catecholamine-treated septic shock显示文摘Bruno L Laure O S Anne M G 2008Crit Care Med2008,28,1:1
12T cell activation-induced and HIV tat-enhanced CD95(APO-1/Fas) ligand transcription involves NF-kappaB显示文摘Li-Weber M Laur O Dem K 2000Eur J Immunol2000,30,:1
13Capillary HPLC-ICP MS mapping of selenocompounds in spots obtained from the 2-D gel electrophoresis of the watersoluble protein fraction of selenized yeast显示文摘Laure Tastet Dirk Schauml o咬ffel Brice Bouyssiere 2006Analytical and Bioanalytical Chemistry2006,385,5:1
14An MHC class Ib-restricted TCR that cross-reacts with an MHC class Ia molecule 显示文摘Reed-Loisel L M Sullivan B A Laur O 2005J Immunol2005,174,:1
15Novel Egr/NF-AT composite mediate activation of the CD95 (APO-1/Fas) lingand promoter in response to T cell stimulation显示文摘Li-Weber M Laur O Krammer PH 1999Eur J Immunol1999,29,9:1
16A regulatory element in the CD95 (APO-1/Fas) ligand promoter is essential responsiveness to TCR-mediated activation显示文摘 LAUR O HEKELE A 2003Eur J Immunol2003,28,:1
17Systematic review and meta-analysis of seroprevalence of human immunodeficiency virus serological markers among pregnant women in Africa, 1984-2020显示文摘BACKGROUND Human immunodeficiency virus(HIV)is a major public health concern,particularly in Africa where HIV rates remain substantial.Pregnant women are at an increased risk of acquiring HIV,which has a significant impact on both maternal and child health.AIM To review summarizes HIV seroprevalence among pregnant women in Africa.It also identifies regional and clinical characteristics that contribute to study-specific estimates variation.METHODS The study included pregnant women from any African country or region,irrespective of their symptoms,and any study design conducted in any setting.Using electronic literature searches,articles published until February 2023 were reviewed.The quality of the included studies was evaluated.The DerSimonian and Laird random-effects model was applied to determine HIV pooled seroprevalence among pregnant women in Africa.Subgroup and sensitivity analyses were conducted to identify potential sources of heterogeneity.Heterogeneity was assessed with Cochran's Q test and I2 statistics,and publication bias was assessed with Egger's test.RESULTS A total of 248 studies conducted between 1984 and 2020 were included in the quantitative synthesis(meta-analysis).Out of the total studies,146(58.9%)had a low risk of bias and 102(41.1%)had a moderate risk of bias.No HIV-positive pregnant women died in the included studies.The overall HIV seroprevalence in pregnant women was estimated to be 9.3%[95%confidence interval(CI):8.3-10.3].The subgroup analysis showed statistically significant heterogeneity across subgroups(P<0.001),with the highest seroprevalence observed in Southern Africa(29.4%,95%CI:26.5-32.4)and the lowest seroprevalence observed in Northern Africa(0.7%,95%CI:0.3-1.3).CONCLUSION The review found that HIV seroprevalence among pregnant women in African countries remains significant,particularly in Southern African countries.This review can inform the development of targeted public health interventions to address high HIV seroprevalence in pregnant women in African countries.Jean Thierry Ebogo-Belobo Sebastien Kenmoe Chris Andre Mbongue Mikangue Serges Tchatchouang Lontuo-Fogang Robertine Guy Roussel Takuissu Juliette Laure Ndzie Ondigui Arnol Bowo-Ngandji Raoul Kenfack-Momo Cyprien Kengne-Ndé Donatien Serge Mbaga Elisabeth Zeuko'o Menkem Ginette Irma Kame-Ngasse Jeannette Nina Magoudjou-Pekam Josiane Kenfack-Zanguim Seraphine Nkie Esemu Paul Alain Tagnouokam-Ngoupo Lucy Ndip Richard Njouom 2023World Journal of Critical Care Medicine2023,12,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费